4,6-DIAMINO-1-(2,3,5-TRI-O-ACETYL-.BETA.-D-RIBOFURANOSYL)-1,3,5-TRIAZIN-2(1H)-ONE
UNII M8N9P2EJ7L
Substance Identification & Data
This profile provides standardized clinical and technical data for 4,6-diamino-1-(2,3,5-tri-o-acetyl-.beta.-d-ribofuranosyl)-1,3,5-triazin-2(1h)-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M8N9P2EJ7L.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1792991-68-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C14H19N5O8 MQCVLUZJVZDPQR-GWOFURMSSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4,6-diamino-1-(2,3,5-tri-o-acetyl-.beta.-d-ribofuranosyl)-1,3,5-triazin-2(1h)-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.